申请人:Basilea Pharmaceutica AG
公开号:US06319933B1
公开(公告)日:2001-11-20
The present invention is directed to new 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives of the formula (I),
and pharmaceutically acceptable salts thereof wherein Q, R, X, Y and Z are the same as defined in the claims and the description. 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives of the present invention have antifungal activity and are useful for the treatment of fungal diseases.
本发明涉及公式(I)的新的1-(1H-1,2,4-三唑-1-基)丁-2-醇衍生物及其药学上可接受的盐,其中Q、R、X、Y和Z如权利要求和说明中所定义。本发明的1-(1H-1,2,4-三唑-1-基)丁-2-醇衍生物具有抗真菌活性,可用于治疗真菌病。